Not applicableUnknownNCT04523116
What this trial is testing
Validation of Tie2 as the First Tumour Vascular Response Biomarker for VEGF Inhibitors: VALTIVE1
Who this might be right for
Ovary Cancer
University of Manchester 176
Showing 2 of 2 results